Cite

HARVARD Citation

    Ahram, M. et al. (n.d.). 125 The androgen receptor agonist, Cl-4AS-1, possesses unique effects on breast cancer cells: A potential therapeutic benefit. European journal of cancer. pp. S8-. [Online]. 
  
Back to record